Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Introduction to Hemostasis01:05

Introduction to Hemostasis

13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Coagulation01:09

Coagulation

9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis.

Nature communications·2025
Same author

Prothrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure Study.

FASEB bioAdvances·2025
Same author

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.

Blood advances·2025
Same author

Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis-Brief Report.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection.

Nature communications·2025

相关实验视频

Updated: Jan 8, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.5K

在感染出血热病毒时出血的潜在机制

Megan V Perkins1,2, Nigel Mackman2,3

  • 1Department of Microbiology and Immunology, University of North Carolina at Chapel Hill. (M.V.P.).

Arteriosclerosis, thrombosis, and vascular biology
|December 18, 2025
PubMed
概括

病毒性出血热 (VHF) 在全球范围内正在增加. 这篇评论探讨了VHF.

关键词:
出血性发烧,埃博拉病毒多个器官衰竭多个器官衰竭这是直肠直肠.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,病毒载量 病毒载量

更多相关视频

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

712
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

相关实验视频

Last Updated: Jan 8, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.5K
Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

712
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

科学领域:

  • * 病毒学和传染病.
  • * 血液学和血液静止.
  • * 病毒感染的病理生理学.

背景情况:

  • * 病毒性出血热 (VHF) 包含由六个家族的病毒引起的各种疾病.
  • *由于载体范围扩大和宿主-病原体相互作用增加,VHF发病率正在上升.
  • * 流血是VHF的标志,源于病毒对静血系统的影响.

研究的目的:

  • * 审查和讨论病毒性出血发烧中出血的潜在机制.
  • *为了突出不同VHF类型的常见和独特的出血路径.
  • * 识别知识缺口和未来研究领域.

主要方法:

  • *对调查VHF出血机制的研究进行文献综述.
  • *分析了来自人类和非人类灵长类动物VHF模型的数据.
  • *对VHF患者的静血参数和生物标志物的检查.

主要成果:

  • *VHF涉及血液静止系统的失调,通过直接的病毒效应和宿主反应.
  • * 机制包括消耗性凝血病,降低凝血因子,血栓缩,血小板功能障碍和内皮损伤.
  • *具体的例子包括埃博拉病毒感染时增加的组织因子和登革热病毒感染时的血栓细胞减小.

结论:

  • *在VHF中出血是影响凝血和血管完整性的因素复杂相互作用的结果.
  • *了解这些机制对于管理VHF患者至关重要.
  • *需要进一步的研究来阐明精确的途径,并开发有针对性的疗法.